Alnylam UK Ltd

Updated December 2023.

Employees say this is a great place to work*

About Alnylam UK Ltd

Company Overview

Alnylam is leading the translation of RNA interference into a whole class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious and central nervous system and ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for treating a wide range of severe, debilitating diseases. Founded in 2002, Alnylam is delivering on a bold vision to turn scientific possibility into reality, with a robust RNAi therapeutics platform. Alnylam is headquartered in Cambridge, MA.

Company Size 113 UK-based Employees
(Medium)

CONNECT

Alnylam UK Ltd Head Office

United Kingdom

Employee Demographics

Tenure

2-5 years - 37%
6-10 years - 58%
11-15 years - 5%

Company Culture at Alnylam UK Ltd

The employee experience below at Alnylam UK Ltd, compared to a typical company.

91% of employees at Alnylam UK Ltd say it is a great place to work*, compared to 54% of employees at a typical UK based company.

Alnylam UK Ltd

91%

Typical Company

54%

*Responses to the statement “Taking everything into account, I would say this is a great place to work.” Source: Great Place To Work® 2021 Global Employee Engagement Study.

100%

People here are treated fairly regardless of their sexual orientation.

99%

This is a physically safe place to work.

99%

I'm proud to tell others I work here.

98%

People here are treated fairly regardless of their sex.

97%

I feel good about the ways we contribute to the community.